ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $95,000 | -82.2% | 22,184 | -86.1% | 0.00% | -87.5% |
| Q1 2021 | $533,000 | +27.8% | 160,048 | +36.2% | 0.01% | +100.0% |
| Q4 2020 | $417,000 | +917.1% | 117,478 | +807.6% | 0.00% | +300.0% |
| Q3 2020 | $41,000 | +32.3% | 12,944 | -23.9% | 0.00% | 0.0% |
| Q2 2020 | $31,000 | +121.4% | 17,000 | +22.6% | 0.00% | 0.0% |
| Q1 2020 | $14,000 | -86.3% | 13,869 | -62.1% | 0.00% | -50.0% |
| Q4 2019 | $102,000 | +67.2% | 36,559 | -7.9% | 0.00% | 0.0% |
| Q3 2019 | $61,000 | – | 39,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |